Find out about events and company news, browse through our press releases, and learn more about our innovations.
Troisdorf, March 18, 2020 | To become more independent from China in the area of medical supply, states increasingly think about setting up own productions. Reifenhäuser Reicofil now supports countries and other investors to implement such projects as speedily as possible by shortening the delivery time to only 3.5 months for Meltblown lines to produce the crucial middle material layer for face masks.
Dr. Bernd Kunze, CEO of Reifenhäuser Reicofil, is convinced that quick and reliable solutions like this are needed in the corona crisis: “In situations like the current one, we gladly depart from customary procedures. Sticking to standards in a non-standard situation is out of place. It goes without saying that we will do everything in our power to serve the needs quickly and in the accustomed high quality.”
The first contract with the new delivery time has already been concluded. The 1.6 meter wide Reicofil Meltblown line is scheduled to start operation in August 2020. With an annual output of 550 metric tons, the plant will produce H99 filter material for up to 1.8 million face masks a day.
Reifenhäuser Reicofil also supplies technology for the production of other medical protection clothing, such as surgical gowns. These products are made of a SMS nonwoven structure – a combination of Spunbond (S) and Meltblown (M) material. The corresponding Reicofil composite lines can be delivered within ten to eleven months.
Reifenhäuser Reicofil GmbH & Co. KG
Reifenhäuser Reicofil, a German plant and machine manufacturer, is the leading global provider of complete Spunbond, Meltblown, and Composite lines. The company has been in business successfully for over 30 years and has installed more than 260 production lines worldwide. It is a member of the family-owned Reifenhäuser Group which specializes in plants and components for plastics extrusion and has a work force of 1600 employees. The CEO of Reifenhäuser Reicofil is Dr. Bernd Kunze.